enGene Therapeutics Inc. (NASDAQ:ENGN) has 59 institutional investors with active 13F positions as of March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FCPM III SERVICES B.V. | 31 Mar, 2026 | 9,632,561 | 0 | 0.00% | $65,597,740.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 5,827,506 | -41,570 | -0.71% | $39,685,316.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 5,253,159 | 1,916,895 | 57.46% | $35,774,013.00 |
| Venrock Adviser, LLC | 31 Mar, 2026 | 4,771,414 | 0 | 0.00% | $32,493,329.00 |
| Blue Owl Capital Holdings LP | 31 Mar, 2026 | 4,416,353 | -2,305,521 | -34.30% | $30,075,364.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 4,377,572 | 0 | 0.00% | $29,811,265.00 |
| BRAIDWELL LP | 31 Mar, 2026 | 2,456,870 | -674,449 | -21.54% | $16,731,285.00 |
| Nextech Invest, Ltd. | 31 Mar, 2026 | 2,324,943 | 200,000 | 9.41% | $15,832,862.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 2,165,000 | 1,110,000 | 105.21% | $14,743,650.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 1,845,373 | 4,475 | 0.24% | $12,566,990.00 |
| Kynam Capital Management, LP | 31 Mar, 2026 | 1,356,843 | -136,055 | -9.11% | $9,240,101.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 1,314,993 | -73,007 | -5.26% | $8,955,102.00 |
| Polar Capital Holdings Plc | 31 Mar, 2026 | 1,224,071 | 81,089 | 7.09% | $8,335,924.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 1,148,997 | 1,148,997 | 0.00% | $7,824,670.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 959,681 | -539,839 | -36.00% | $6,535,428.00 |
| Omega Fund Management, LLC | 31 Mar, 2026 | 876,357 | 0 | 0.00% | $5,967,991.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Mar, 2026 | 747,750 | 0 | 0.00% | $5,092,178.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 610,370 | -33,000 | -5.13% | $4,156,620.00 |
| Eversept Partners, LP | 31 Mar, 2026 | 510,543 | 54,708 | 12.00% | $3,476,798.00 |
| KENNEDY CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 425,781 | 349,016 | 454.66% | $2,899,569.00 |